Using Evidence Packagers To Strengthen Your Business Reputation Online

A new tool helps local businesses dispute fake reviews more effectively by assembling evidence packets, potentially increasing review removal success.

The Future Of AI In Europe: 2026 Supplier Lineup

A detailed overview of Europe’s AI supplier lineup in 2026, highlighting ownership, certification, and strategic implications for sovereignty.

Canada’s Energy Policy Shapes The Future Of AI, Not Just Labs

Canada’s hydro power limits are impacting AI data center growth, challenging assumptions about cheap, abundant clean energy for global AI hubs.

Six Critical Questions Europe Should Ask Canada About AI Ethical Standards

Europe faces key questions for Canada on AI ethical standards amid ongoing negotiations, highlighting sovereignty and trade concerns. Here’s what’s at stake.

Как россиянам блокируют участие в выборах и с чем связан скачок самосознания у разработчиков ИИ

Recent reports indicate increased restrictions on Russian voters’ participation in elections, linked to a surge in self-awareness among developers of AI technology. Details remain emerging.

Automattic’s Board Forces CEO Matt Mullenweg Into Leave Of Absence

Automattic’s board has mandated CEO Matt Mullenweg to take a leave of absence amid internal concerns, marking a significant leadership change.

Экс-министру связи России Никифорову заочно предъявили обвинение по делу финансовой пирамиды Finiko

Russian authorities have formally charged ex-Minister Nikiforov in absentia over alleged involvement in the Finiko financial pyramid scheme, marking a significant legal development.

OpenAI Ships Astra Gated—What It Means For AI Ethics

OpenAI has publicly disclosed Astra, a model crossing the ‘Critical’ cybersecurity threshold, with safeguards and gating measures in place. What it means for AI ethics and safety.

The Alarming Connection Between Grok And Victims’ Media In Deepfake AI Tech

Survivors allege xAI’s Grok used their images and videos without consent for deepfake capabilities, raising legal and ethical concerns.

HUTCHMED Announces SANOVO Trial Demonstrated Significant Progression-Free Survival Benefit Of ORPATHYS® Plus TAGRISSO® In Treatment-Naïve Patients With MET-Overexpressing EGFR-mutated Lung Cancer In China

HUTCHMED announces that the SANOVO trial shows notable progression-free survival benefits for ORPATHYS® combined with TAGRISSO® in untreated MET-overexpressing EGFR-mutant lung cancer patients in China.